Device Trial Radar · NCT04741685
Clinical Efectivity of Two Different Sensor-augmented Pumps With Low Predictive Suspension Function
Last checked: Nov 19, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Feb 15, 2021
Primary completion
Jun 1, 2021
Study completion Jun 10, 2021
Sponsor
- Lead sponsor
- Castilla-La Mancha Health ServiceAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 5, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Observational cross-sectional multicenter study about effectiveness of two different sensor augmented-pumps with low glucose predictive function in Type 1 Diabetes Mellitus (T1DM) adult patients in routine clinical practice.
Conditions
- Type 1 Diabetes
Interventions
TTSX2Device
Treatment with Tandem T Slim X2 with Basal IQ
MM640GDevice
Treatment with Medtronic Minimed 640G with Smartguard
Primary outcomes
What the sponsor says the trial is designed to measure.
- TIRTime frame: during the procedure
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Badajoz University Hospital
Badajoz, Spain
Obispo Rafael Torija, St.
Ciudad Real, Spain
Nuestra Señora de la Candelaria University Hospital
Santa Cruz de Tenerife, Santa Cruz De Tenerife, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.